Parkinson's Disease Trial, Recruiting NCT06329453 Sponsor: Yale University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06329453
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been recommended to have a routine screening colonoscopy (and possibly a throat/stomach scope) as part of your normal medical care — this includes healthy people as well as those with neurological or autoimmune conditions
  • OR you are willing to have a colonoscopy (and possibly a throat/stomach scope) specifically for the purposes of this research study

Who may not be able to join:

  • You are currently pregnant (women who could potentially be pregnant will be asked to take a urine pregnancy test before the procedure)
  • You have been diagnosed with, or are suspected to have, a long-term inflammatory bowel condition, such as Crohn's disease or ulcerative colitis
  • You have a known active or ongoing infection of any kind
  • You have taken antibiotic pills or IV antibiotics within the last 3 months
  • You have taken steroid medications (such as prednisone at a moderate-to-high dose) for more than 5 days within the last 2 weeks
  • You have been diagnosed with or treated for cancer within the last 5 years
  • You have taken probiotic supplements within the last 2 weeks
  • You have had major surgery on your digestive system in the past, such as removal of part of the colon or gastric bypass surgery
  • You have a bleeding disorder or take blood-thinning medications
  • You have another medical condition that the study doctor believes would make taking a small tissue sample (biopsy) riskier than normal (confirm with trial site)
  • You have a known allergy to the type of sedation or other medications typically used during this kind of procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erin Longbrake, Yale University

Phone: 2032876100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
2 August 2022
Est. completion
31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Characterization of immune cells from the gastrointestinal mucosa

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov